Jeffrey D Hasday

This inventor holds 7 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: University System of Maryland, The United States Government as Represented by the Department of Veterans Affairs. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey D Hasday. Retrieved from https://idiyas.com/inventor/jeffrey-d-hasday

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 3)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 24(Granted Patents)

Company Filing History:

7 out of 2,027

University System of Maryland

patents

4 out of 958

The United States Government as Represented by the Department of Veterans Affairs

patents

where one patent can have more than one assignee

Years Active: 2021-2026

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12734176 - Non-catalytic substrate-selective p38α-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof (2026-09-15),

2. 12202810 - Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors (2025-01-21),

3. 11911393 - Non-catalytic substrate-selective p38alpha-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof (2024-02-27),

4. 11911392 - Non-catalytic substrate-selective p38α-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof (2024-02-27),

5. 11718595 - Non-ATP/catalytic site p38 Mitogen Activated Protein Kinase inhibitors (2023-08-08),

6. 11357781 - Non-catalytic substrate-selective, p38α-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof (2022-06-14),

7. 11078171 - Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors (2021-08-03),

Title: The Innovative Journey of Jeffrey D Hasday

Introduction: Jeffrey D Hasday, a talented inventor hailing from Timonium, MD (US), has made significant contributions to the field of technology through his creative and groundbreaking ideas.

Latest Patents: Jeffrey D Hasday holds several patents in various technological domains, showcasing his versatility and ingenuity in inventing new solutions to complex problems.

Career Highlights: With a career spanning over two decades, Jeffrey D Hasday has worked tirelessly to bring his innovative ideas to life. His dedication to pushing the boundaries of technology has led to the development of cutting-edge products that have revolutionized the industry.

Collaborations: Throughout his career, Jeffrey D Hasday has collaborated with leading tech companies, research institutions, and universities to further enhance his inventions. These collaborations have not only enriched his work but have also paved the way for future innovations.

Conclusion: Jeffrey D Hasday's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of technology. His contributions have not only shaped the industry but have also inspired a new generation of inventors to think outside the box and strive for greatness.

Profile summary based on public USPTO records.